Accelerated partial-breast irradiation: the current state of our knowledge

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Breast-conserving therapy (BCT) with segmental mastectomy and whole-breast irradiation (WBI) is standard for early-stage breast cancer.
• Mastectomy is an alternative, but BCT is preferred for suitable candidates.
• Accelerated partial-breast irradiation (APBI) is an emerging, shorter-course radiation alternative for specific patients.

Purpose of the Study:

• To review the various methods for delivering APBI.
• To discuss the potential advantages and disadvantages of APBI.
• To compare APBI with traditional WBI for early-stage breast cancer treatment.

Main Methods:

• Literature review of APBI delivery techniques.
• Analysis of clinical studies and outcomes data for APBI.
• Discussion of benefits and harms based on current evidence.

Main Results:

• Several APBI modalities exist, offering different delivery schedules.
• APBI may provide comparable efficacy to WBI for select patients.
• Potential benefits include reduced treatment time and toxicity, but long-term data is still evolving.

Conclusions:

• APBI is a viable, shorter-course radiation option for carefully selected early-stage breast cancer patients.
• Understanding the different APBI techniques is crucial for optimal patient selection and treatment planning.
• Further research is needed to fully establish the long-term outcomes and comparative effectiveness of APBI versus WBI.